BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 28186503)

  • 1. A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation.
    Palazzo E; Kellett MD; Cataisson C; Bible PW; Bhattacharya S; Sun HW; Gormley AC; Yuspa SH; Morasso MI
    Cell Death Differ; 2017 Apr; 24(4):717-730. PubMed ID: 28186503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of murine homeodomain protein Dlx3 by protein kinase C.
    Park GT; Denning MF; Morasso MI
    FEBS Lett; 2001 May; 496(1):60-5. PubMed ID: 11343707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion.
    Wang HQ; Smart RC
    J Cell Sci; 1999 Oct; 112 ( Pt 20)():3497-506. PubMed ID: 10504298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C-alpha coordinately regulates cytosolic phospholipase A(2) activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes.
    Wang HQ; Kim MP; Tiano HF; Langenbach R; Smart RC
    Mol Pharmacol; 2001 Apr; 59(4):860-6. PubMed ID: 11259631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of proline-rich protein tyrosine kinase 2 in differentiation-dependent signaling in human epidermal keratinocytes.
    Schindler EM; Baumgartner M; Gribben EM; Li L; Efimova T
    J Invest Dermatol; 2007 May; 127(5):1094-106. PubMed ID: 17205062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways.
    Cataisson C; Joseloff E; Murillas R; Wang A; Atwell C; Torgerson S; Gerdes M; Subleski J; Gao JL; Murphy PM; Wiltrout RH; Vinson C; Yuspa SH
    J Immunol; 2003 Sep; 171(5):2703-13. PubMed ID: 12928424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLX3-Dependent STAT3 Signaling in Keratinocytes Regulates Skin Immune Homeostasis.
    Bhattacharya S; Kim JC; Ogawa Y; Nakato G; Nagle V; Brooks SR; Udey MC; Morasso MI
    J Invest Dermatol; 2018 May; 138(5):1052-1061. PubMed ID: 29246798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PKC-Sp1 signaling pathway induces early differentiation of human keratinocytes through upregulation of TSG101.
    You HL; Eng HL; Hsu SF; Chen CM; Ye TC; Liao WT; Huang MY; Baer R; Cheng JT
    Cell Signal; 2007 Jun; 19(6):1201-11. PubMed ID: 17321722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation.
    Cataisson C; Pearson AJ; Tsien MZ; Mascia F; Gao JL; Pastore S; Yuspa SH
    J Clin Invest; 2006 Oct; 116(10):2757-66. PubMed ID: 16964312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth.
    Palazzo E; Kellett M; Cataisson C; Gormley A; Bible PW; Pietroni V; Radoja N; Hwang J; Blumenberg M; Yuspa SH; Morasso MI
    Oncogene; 2016 Jun; 35(24):3114-24. PubMed ID: 26522723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin.
    Kim S; Hong I; Hwang JS; Choi JK; Rho HS; Kim DH; Chang I; Lee SH; Lee MO; Hwang JS
    Mol Med; 2006; 12(1-3):17-24. PubMed ID: 16838068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?
    Palazzo E; Marconi A; Pincelli C; Morasso MI
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo.
    Cataisson C; Pearson AJ; Torgerson S; Nedospasov SA; Yuspa SH
    J Immunol; 2005 Feb; 174(3):1686-92. PubMed ID: 15661932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal ablation of Dlx3 is linked to IL-17-associated skin inflammation.
    Hwang J; Kita R; Kwon HS; Choi EH; Lee SH; Udey MC; Morasso MI
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11566-71. PubMed ID: 21709238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
    Bajpai D; Mehdizadeh S; Uchiyama A; Inoue Y; Sawaya A; Overmiller A; Brooks SR; Hasneen K; Kellett M; Palazzo E; Motegi SI; Yuspa SH; Cataisson C; Morasso MI
    Oncogene; 2021 May; 40(21):3680-3694. PubMed ID: 33947961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes.
    Park GT; Morasso MI
    Nucleic Acids Res; 2002 Jan; 30(2):515-22. PubMed ID: 11788714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Dlx3 homeobox gene upon differentiation of mouse keratinocytes.
    Park GT; Morasso MI
    J Biol Chem; 1999 Sep; 274(37):26599-608. PubMed ID: 10473625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of N-acetylglucosaminyltransferase-V by heparin-binding EGF-like growth factor induces keratinocyte proliferation and epidermal hyperplasia.
    Kimura A; Terao M; Kato A; Hanafusa T; Murota H; Katayama I; Miyoshi E
    Exp Dermatol; 2012 Jul; 21(7):515-9. PubMed ID: 22716246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for protein kinase C-alpha in keratinocyte growth arrest.
    Jerome-Morais A; Rahn HR; Tibudan SS; Denning MF
    J Invest Dermatol; 2009 Oct; 129(10):2365-75. PubMed ID: 19340015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.